Why Centrus Energy Stock Heated Up Today

Centrus Energy announced a move into centrifuge manufacturing with a factory in Oak Ridge, Tenn., to supply centrifuges for LEU and HALEU enrichment at its Piketon, Ohio facility, driving a 14.2% intraday share jump. The company cites $2.3 billion of supply contracts, expects Department of Energy task orders it values at roughly $900 million each for LEU and HALEU, and has secured $1.2 billion via convertible notes, holds $1.6 billion cash, and plans a $1 billion equity raise; centrifuge production is slated to begin in 2029. The plan accelerates U.S. domestic enrichment capacity but remains contingent on imminent DOE awards and multi-year buildout timing.

Analysis

Market structure: Centrus (LEU) becoming a domestic centrifuge maker is a direct win for U.S. fuel-security incumbents (LEU, BWXT) and utilities planning HALEU-fed advanced reactors, and a medium-term negative for non‑U.S. enrichment incumbents that rely on export markets. Shift raises U.S. pricing power for LEU/HALEU by internalizing margin capture (centrifuge → enrichment → fuel sales), but production only materializes in 2029 so near‑term supply remains tight supporting uranium spot (U3O8) and miner economics.

Risk assessment: Key tail risks are DOE funding withdrawal (~$900m/task order risk), NRC/regulatory delays, centrifuge tech failure, and financing dilution from convertibles and recent equity raises; any of these can wipe out >50% equity value before 2029. Near term (days–months) volatility will track DOE award news (expected imminently within 30–90 days); long term (2029+) execution and capital intensity dominate returns.

Trade implications: Tactical play: small equity exposure to LEU (2–3% portfolio) plus long-dated options to lever upside on DOE confirmation; complement with 2–4% exposure to URA (Global X Uranium) to capture spot tightness. Use 12–24 month call spreads on LEU to limit premium decay if DOE award is the binary catalyst; consider pair trade long LEU vs short select foreign enrichment/merchant names if/when U.S. policy clearly favors domestic supply.

Contrarian angles: Consensus underestimates legacy execution risk — Centrus descended from USEC history and must prove manufacturing scale by 2029; market may be under-pricing potential dilution from further capital raises. Reaction may be partly overdone: a 14% one‑day move prices in DOE certainty and smooth execution; if award delayed >90 days, expect a >30% pullback and a buying window.

Key Decisions for Investors

• Establish a tactical 2–3% long equity position in Centrus Energy (LEU) now; hedge with a 12–24 month LEAP call (buy LEU Jan 2027/Jan 2028 calls) sized to cover ~50% of the equity notional to cap downside. Set a hard stop-loss at -35% on the equity tranche and plan to add another 2–3% only on confirmed DOE task‑order award within 30–90 days.
• Allocate 2–4% to URA (Global X Uranium ETF) as a thematic hedge to capture ongoing U3O8 tightness; increase to 6% if Centrus receives the DOE award or if spot uranium rises >25% from current levels within 6 months.
• Buy a tactical call spread on LEU (12–18 month expiration) to speculate on imminent DOE award: long-dated call financed by selling a higher strike call to limit premium. If DOE award confirmed, close the spread and convert proceeds into incremental LEU equity size up to +3% portfolio.
• Monitor three specific triggers over next 30–90 days: (1) official DOE task order award (if awarded, add to LEU), (2) any NRC/regulatory notices or production timeline shifts (if delayed >180 days, reduce LEU exposure by 50%), and (3) quarterly cash-burn and convertible-note covenants (if covenant/waterfall risk appears, tighten stop-loss to -20%).